GLA
GILD icon

Good Life Advisors’s Gilead Sciences GILD Stock Holding History

Good Life Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$577K Buy
5,205
+476
+10% +$50.7K 0.04% 284
2025
Q1 		$530K Sell
4,729
-139
-3% -$14.3K 0.04% 288
2024
Q4 		$450K Sell
4,868
-6,748
-58% -$608K 0.03% 308
2024
Q3 		$974K Buy
11,616
+7,171
+161% +$547K 0.06% 225
2024
Q2 		$305K Buy
4,445
+442
+11% +$29.5K 0.03% 355
2024
Q1 		$293K Buy
4,003
+328
+9% +$25.2K 0.03% 353
2023
Q4 		$298K Sell
3,675
-429
-10% -$33.4K 0.03% 329
2023
Q3 		$308K Sell
4,104
-51
-1% -$3.92K 0.04% 307
2023
Q2 		$320K Buy
4,155
+1,257
+43% +$100K 0.04% 299
2023
Q1 		$240K Buy
2,898
+405
+16% +$33.5K 0.03% 332
2022
Q4 		$214K Buy
+2,493
New +$197K 0.03% 318
2020
Q3 		– Sell
-2,689
Closed -$206K – 258
2020
Q2 		$206K Buy
+2,689
New +$206K 0.06% 227
2019
Q1 		– Sell
-3,822
Closed -$239K – 251
2018
Q4 		$239K Sell
3,822
-196
-5% -$13.7K 0.08% 194
2018
Q3 		$307K Buy
4,018
+2
+0% +$151 0.09% 170
2018
Q2 		$283K Sell
4,016
-179
-4% -$12.6K 0.09% 169
2018
Q1 		$306K Sell
4,195
-195
-4% -$15.5K 0.1% 148
2017
Q4 		$327K Sell
4,390
-9
-0.2% -$683 0.1% 152
2017
Q3 		$357K Buy
4,399
+689
+19% +$52.7K 0.14% 123
2017
Q2 		$258K Sell
3,710
-77
-2% -$5.12K 0.11% 158
2017
Q1 		$252K Buy
+3,787
New +$266K 0.12% 157

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Good Life Advisors's GILD Position: Q2 2025 in Review

Good Life Advisors increased its Gilead Sciences (GILD) stake by 10% in Q2 2025, buying an estimated $50.7K and bringing the position to 5,205 shares worth $577K. The position accounts for 0.04% of the portfolio, ranked #284.

Good Life Advisors first reported a position in GILD in Q1 2017 and has held it in 20 quarters since. The position peaked at $974K in Q3 2024. 2,024 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Good Life Advisors held 5,205 shares of Gilead Sciences worth $577K as of Q2 2025.
  • Good Life Advisors bought 476 Gilead Sciences shares in Q2 2025, an estimated $50.7K.
  • Gilead Sciences made up 0.04% of Good Life Advisors's portfolio in Q2 2025, its #284 holding.
  • Good Life Advisors first reported a position in Gilead Sciences in Q1 2017 and has held it in 20 quarters since.
  • Good Life Advisors's Gilead Sciences position peaked at $974K in Q3 2024.
  • 2,024 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Good Life Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.